Biotech

All Articles

A better consider Strong Biotech's Brutal 15

.In this particular week's episode of "The Top Line," we're diving in to Brutal Biotech's annual Str...

Lilly encounters stage 2 failing of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's gathering celebrating the commendati...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as w...

Lykos will certainly talk to FDA to reevaluate its choice following being rejected of MDMA therapy for trauma

.Following an inadequate showing for Lykos Therapies' MDMA prospect for trauma at a latest FDA consu...

AN 2 one-halfs census, quits period 3 test after information let down

.AN2 Therapies is actually reconsidering its organization in reaction to dull midphase information, ...

Merck pays $700M for bispecific, spying autoimmune position and also possibility to challenge Amgen in cancer cells

.Merck &amp Co. is paying out $700 million in advance to challenge Amgen in a blood stream cancer ma...

Gilead pays for J&ampJ $320M to go out licensing package for seladelpar

.Along With Gilead Sciences about to an FDA decision for its liver illness medication seladelpar, th...

' All palms on deck' at Lilly as peers target weight problems market

.Chief executive officer David Ricks can find the companies putting together camping tents at baseca...

Entero laying off team, moving out of office and pausing R&ampD

.Bed mattress Liquidators has transformed Entero Therapeutics white colored as a sheet. The financia...

Exelixis loses ADC after choosing it is actually no suit for Tivdak

.Exelixis is actually giving up on its own tissue aspect (TF)- targeting antibody-drug conjugate aft...